Cell transplantation for ischemic heart disease

Jianyi J Zhang, Daniel J Garry

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Recent studies support the notion that cardiomyocyte regeneration may occur during physiological and pathological states in the adult heart. These data highlight the possibilities that myocardial regeneration may occur via cardiomyocyte proliferation and/or differentiation of putative cardiac stem cells. To date, various cell types have been used for cardiac repair, including skeletal myoblasts, bone marrow-derived cells, mesenchymal stem cells (MSCs), endothelial progenitor cells (EPCs), umbilical cord blood (UCB) stem cells, cardiac stem cells, and embryonic stem cells (ESCs). This chapter will review each of these different stem cell populations in regards to the potential treatment of heart disease. We will examine the in vitro and in vivo animal studies, and then briefly discuss the cell therapy clinical trials that are currently underway for the treatment of ischemic heart disease.

Original languageEnglish (US)
Title of host publicationHandbook of Cardiac Anatomy, Physiology, and Devices, Third Edition
PublisherSpringer International Publishing
Pages733-749
Number of pages17
ISBN (Electronic)9783319194646
ISBN (Print)9783319194639
DOIs
StatePublished - Jan 1 2015

Keywords

  • Adult stem cells
  • Bone marrow-derived stem cells
  • Cardiac stem cells
  • Embryonic stem cells
  • Endothelial progenitor cells
  • Mesenchymal stem cells
  • Skeletal myoblasts
  • Umbilical cord blood stem cells

Fingerprint Dive into the research topics of 'Cell transplantation for ischemic heart disease'. Together they form a unique fingerprint.

Cite this